Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Peer Christiansen"'
Autor:
Per Damkier, Timothy L. Lash, Thomas P. Ahern, Henrik Toft Sørensen, Deirdre Cronin-Fenton, Bent Ejlertsen, Peer Christiansen
Publikováno v:
Cronin-Fenton, D, Lash, T L, Ahern, T P, Damkier, P, Christiansen, P, Ejlertsen, B & Sørensen, H T 2018, ' Concurrent new drug prescriptions and prognosis of early breast cancer : studies using the Danish Breast Cancer Group clinical database ', Acta Oncologica, vol. 57, no. 1, pp. 1-9 . https://doi.org/10.1080/0284186X.2017.1407040
BACKGROUND: Myriad reports suggest that frequently used prescription drugs alter the viability of breast cancer cells in pre-clinical studies. Routine use of these drugs, therefore, may impact breast cancer prognosis, and could have important implica
Autor:
Mette Nørgaard, Anne Marie L. Thomsen, Nickolaj R. Kristensen, Bjarne Kuno Møller, Deirdre Cronin-Fenton, Alma B Pedersen, Peer Christiansen, Christian Erikstrup
Publikováno v:
Breast Cancer Research : BCR
Thomsen, A M L, Pedersen, A B, Kristensen, N R, Møller, B K, Erikstrup, C, Christiansen, P M, Nørgaard, M & Cronin-Fenton, D 2017, ' Use of prescription drugs and risk of postoperative red blood cell transfusion in breast cancer patients : a Danish population-based cohort study ', Breast Cancer Research (Online Edition), vol. 19, no. 1, pp. 135 . https://doi.org/10.1186/s13058-017-0926-2
Breast Cancer Research, Vol 19, Iss 1, Pp 1-8 (2017)
Thomsen, A M L, Pedersen, A B, Kristensen, N R, Møller, B K, Erikstrup, C, Christiansen, P M, Nørgaard, M & Cronin-Fenton, D 2017, ' Use of prescription drugs and risk of postoperative red blood cell transfusion in breast cancer patients : a Danish population-based cohort study ', Breast Cancer Research (Online Edition), vol. 19, no. 1, pp. 135 . https://doi.org/10.1186/s13058-017-0926-2
Breast Cancer Research, Vol 19, Iss 1, Pp 1-8 (2017)
Background Several frequently used prescription drugs may affect bleeding risk. We investigated use of aspirin, nonsteroidal anti-inflammatory drugs (NSAIDs), selective serotonin reuptake inhibitors (SSRIs), and statins and risk of postoperative red
Autor:
Bent Ejlertsen, Thomas P. Ahern, Uffe Heide-Jørgensen, Peer Christiansen, Deirdre P. Cronin-Fenton, Timothy L. Lash, Henrik Toft Sørensen
Publikováno v:
Cronin-Fenton, D P, Heide-Jørgensen, U, Ahern, T P, Lash, T L, Christiansen, P, Ejlertsen, B & Sørensen, H T 2016, ' Low-dose aspirin, non-steroidal anti-inflammatory drugs, selective COX-2 inhibitors and breast cancer recurrence ', Epidemiology . https://doi.org/10.1097/EDE.0000000000000480
BACKGROUND: Aspirin, non-steroidal anti-inflammatory drugs (NSAIDs), and selective COX-2 inhibitors may improve outcomes in breast cancer patients. We investigated the association of aspirin, NSAIDs, and use of selective COX-2 inhibitors with breast